Clal Biotechnology reported ILS-0.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2022.





Eps Change Date
aTyr Pharma USD -0.26 0.05 Sep/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.08 0 Sep/2025
RedHill Biopharma USD -1.31 33.38 Jun/2024